Medacta Group SA Financials

Market Capitalization CHF2.12 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	40.46
Forward PE	26.67
Price to Sales TTM	CHF3.90
Price to Book MRQ	CHF6.17
Enterprise to Revenue	4.29
Enterprise to EBITDA	18.66

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	10.33%
Operating Margin	15.78%
Return on Assets TTM	7.11%
Return on Equity TTM	17.52%

Income Statement

Revenue TTM	CHF506,839,154
Revenue per Share TTM	CHF27.30
Quarterly Revenue Growth	13.10%
Gross Profit TTM	CHF347,847,000
EBITDA	CHF121,735,000
Net Income to Common TTM	CHF52,343,684
Diluted EPS TTM	CHF2.63
Quarterly Earnings Growth YoY	30.40%

Balance Sheet

Total Cash MRQ	CHF15,284,717
Total Cash per Share MRQ	CHF0.82
Total Debt MRQ	CHF
Total Debt to Equity MRQ	67.08
Current Ratio MRQ	2.20
Book Value per Share MRQ	CHF17.25

Cash Flow

Operating Cash Flow TTM	CHF74,032,264
Levered Free Cash Flow TTM	CHF-27,937,047

MOVE Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	19,951,600
Float Shares	6,026,575
Avg 10 Volume	9,676
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	69.63%
% Held by Institutions	16.32%

Stock Price Summary

Beta	1.16
Fifty Two Week Low	CHF103.60
Fifty Two Week High	CHF135.00
Fifty Two Week Change	-16.94%
Day 50 MA	CHF113.09
Day 200 MA	CHF120.02

Dividends and Splits

Forward Annual Dividend Rate	CHF2.20
Forward Annual Dividend Yield	1.98%
Trailing Annual Dividend Rate	CHF0.55
Trailing Annual Dividend Yield	0.50%
Payout Ratio	20.00%
Dividend Date	2024-05-14
Ex Dividend Date	2024-05-10
Last Split Factor
Last Split Date